Editorial: when to start carvedilol in cirrhosis-time to reconsider? Authors' reply

被引：1
|
作者：
Wijarnpreecha, Karn [1 ]
Li, Fang [2 ]
Taner, C. Burcin [1 ]
Yang, Liu [1 ]
Tao, Cui [2 ]
机构：
[1] Mayo Clin, Dept Transplantat, Jacksonville, FL 32224 USA
[2] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 54卷 / 05期
关键词：
D O I：
10.1111/apt.16526
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：728 / 729
页数：2
相关论文
共 50 条
  • [1] Editorial: when to start carvedilol in cirrhosis-time to reconsider?
    Gillespie, Sarah-Louise
    Hayes, Peter C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (05) : 726 - 727
  • [2] Editorial: when cirrhosis deserves haemodialysis-rethinking strategies. Authors' reply
    Artru, Florent
    Louvet, Alexandre
    Hazzan, Marc
    Mathurin, Philippe
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (04) : 457 - 458
  • [3] Editorial: neutrophil dysfunction in patients with cirrhosis - authors' reply
    Taylor, N. J.
    Ma, Y.
    Shawcross, D. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (08) : 987 - 987
  • [4] Editorial: Navigating the Beta-Blocker Dilemma in Advanced Liver Cirrhosis-When Is the Right Time to Discontinue? Authors' Reply
    Wang, Ting
    Zou, Deli
    Qi, Xingshun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (01) : 194 - 197
  • [5] Editorial: optimal dose of carvedilol in portal hypertension ... nearly there. Authors' reply
    Reiberger, T.
    Ferlitsch, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (09) : 1329 - 1330
  • [6] Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' reply
    Bettinger, D.
    Knueppel, E.
    Euringer, W.
    Spangenberg, H. C.
    Roessle, M.
    Thimme, R.
    Schultheiss, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (02) : 231 - 231
  • [7] Editorial: sepsis in cirrhosis - there may be trouble ahead; authors' reply
    Salameh, H.
    Kamath, P. S.
    Singal, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (05) : 567 - 568
  • [8] Editorial: risk factors for persistent villus atrophy in coeliac disease - is it time to reconsider definitions for refractory coeliac disease? Authors' reply
    Mahadev, S.
    Murray, J. A.
    Green, P. H. R.
    Adelman, D. A.
    Lebwohl, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1478 - 1479
  • [9] Editorial: moving towards a robust definition of sarcopenia in cirrhosis-authors' reply
    Engelmann, Cornelius
    Schob, Stefan
    Seehofer, Daniel
    Berg, Thomas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (03) : 341 - 342
  • [10] Editorial: the role of statins in the treatment of alcohol-related cirrhosis - Authors' reply
    Bang, U. C.
    Benfield, T.
    Bendtsen, F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (09) : 893 - 894
12345